Cargando…

Visualizing Molecular Profiles of Glioblastoma with GBM-BioDP

Validation of clinical biomarkers and response to therapy is a challenging topic in cancer research. An important source of information for virtual validation is the datasets generated from multi-center cancer research projects such as The Cancer Genome Atlas project (TCGA). These data enable invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celiku, Orieta, Johnson, Seth, Zhao, Shuping, Camphausen, Kevin, Shankavaram, Uma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091869/ https://www.ncbi.nlm.nih.gov/pubmed/25010047 http://dx.doi.org/10.1371/journal.pone.0101239

Ejemplares similares

Glioma-BioDP: database for visualization of molecular profiles to improve prognosis of brain cancer
por: Deng, Xiang, et al.
Publicado: (2023)

SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment
por: Deng, Xiang, et al.
Publicado: (2019)

StRAP: An Integrated Resource for Profiling High-Throughput Cancer Genomic Data from Stress Response Studies
por: Johnson, Seth, et al.
Publicado: (2012)

Computational analysis of the mesenchymal signature landscape in gliomas
por: Celiku, Orieta, et al.
Publicado: (2017)

Molecular profiling of MPS1 gene silencing in U251 glioma cell line
por: Shankavaram, Uma, et al.
Publicado: (2015)

Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma
por: Shankavaram, Uma T, et al.
Publicado: (2012)

Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma
por: Kambach, Diane M., et al.
Publicado: (2017)

Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation
por: Celiku, Orieta, et al.
Publicado: (2019)

Modulation of miR-21 signaling by MPS1 in human glioblastoma
por: Maachani, Uday B., et al.
Publicado: (2015)

FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
por: Maachani, Uday B., et al.
Publicado: (2016)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic Data
por: Das, Shaoli, et al.
Publicado: (2020)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019)

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology
por: Sproull, Mary, et al.
Publicado: (2021)

Glioblastoma cells have increased capacity to repair radiation-induced DNA damage after migration to the olfactory bulb
por: Degorre, Charlotte, et al.
Publicado: (2022)

Synthetic Lethal Drug Combinations Targeting Proteasome and Histone Deacetylase Inhibitors in TP53-Mutated Cancers
por: Das, Shaoli, et al.
Publicado: (2020)

Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose
por: Sproull, Mary, et al.
Publicado: (2013)

Dp71 Expression in Human Glioblastoma
por: Ruggieri, Simona, et al.
Publicado: (2019)

Mitochondrial DNA Alterations in Glioblastoma (GBM)
por: Leão Barros, Mariceli Baia, et al.
Publicado: (2021)

Chemoirradiation for Glioblastoma Multiforme: The National Cancer Institute Experience
por: Ho, Jennifer, et al.
Publicado: (2013)

Radiation-induced alternative transcripts as detected in total and polysome-bound mRNA
por: Wahba, Amy, et al.
Publicado: (2017)

Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups
por: Hinrichs, Benjamin H., et al.
Publicado: (2016)

Clinical outcome assessment trends in clinical trials—Contrasting oncology and non‐oncology trials
por: Kim, Yeonju, et al.
Publicado: (2023)

Analytical Considerations of Large-Scale Aptamer-Based Datasets for Translational Applications
por: Jiang, Will, et al.
Publicado: (2022)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020)

FAM72, Glioblastoma Multiforme (GBM) and Beyond
por: Ho, Nguyen Thi Thanh, et al.
Publicado: (2021)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
por: Binder, Zev A., et al.
Publicado: (2016)

Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)
por: Krauze, Andra V, et al.
Publicado: (2013)

Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells
por: Mukherjee, Sumit, et al.
Publicado: (2018)

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
por: Krauze, Andra V., et al.
Publicado: (2023)

Revealing Angiopep-2/LRP1 Molecular Interaction for Optimal Delivery to Glioblastoma (GBM)
por: di Polidoro, Angela Costagliola, et al.
Publicado: (2022)

Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel
por: Krauze, Andra Valentina, et al.
Publicado: (2023)

DDRE-08. NRF2/GLUTATHIONE METABOLISM AS A NOVEL THERAPEUTIC TARGET FOR IDH1-MUTATED GLIOMA
por: Liu, Yang, et al.
Publicado: (2021)

Probabilistic model checking of cancer metabolism
por: Friedenberg, Meir D., et al.
Publicado: (2022)

Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds
por: Liu, Hui, et al.
Publicado: (2022)

Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy
por: Mehrabian, Hatef, et al.
Publicado: (2018)

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023)

Migration-Associated Transportome and Therapeutic Potential in Glioblastoma Multiforme (GBM)
por: Vaid, Samir, et al.
Publicado: (2023)

Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM)
por: Demeure, Kevin, et al.
Publicado: (2016)

The Next Frontier in Health Disparities—A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back
por: Diaz Rosario, Maria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nidhb55amdo9qsgs2shat7tilg